prednisolone has been researched along with Hyperprolactinemia in 3 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Hyperprolactinemia: Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty-one consecutive patients with hyperprolactinaemia (serum prolactin > 1000 mU/l on 3 separate occasions) who were due to start depot bromocriptine and who had a normal cortisol response to insulin-induced hypoglycaemia." | 5.08 | Oral prednisolone supplement abolishes the acute adverse effects following initiation of depot bromocriptine therapy. ( Besser, GM; Grossman, AB; Jain, A; Jenkins, PJ; Jones, SL, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Celik, O | 1 |
| Kalfa, M | 1 |
| Celebi, ARC | 1 |
| Cabuk, B | 1 |
| Ceylan, S | 1 |
| Jenkins, PJ | 1 |
| Jain, A | 1 |
| Jones, SL | 1 |
| Besser, GM | 1 |
| Grossman, AB | 1 |
| Kelestimur, F | 1 |
1 trial available for prednisolone and Hyperprolactinemia
| Article | Year |
|---|---|
Oral prednisolone supplement abolishes the acute adverse effects following initiation of depot bromocriptine therapy.
Topics: Administration, Oral; Adult; Bromocriptine; Delayed-Action Preparations; Double-Blind Method; Drug A | 1996 |
2 other studies available for prednisolone and Hyperprolactinemia
| Article | Year |
|---|---|
Granulomatosis With Polyangiitis as an Uncommon Cause of Panhypopituitarism.
Topics: Aged; Antirheumatic Agents; Biopsy; Endoscopy; Female; Granulomatosis with Polyangiitis; Humans; Hyp | 2019 |
Hyperprolactinemia in a patient with Sheehan's syndrome.
Topics: Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Hydrocortisone; Hyperprolactinemia; Hy | 1992 |